Interest of a 30 Minutes' Intermittent Work Exercise Test in Patients With Chronic Obstructive Pulmonary Disease: Cardiac and Pulmonary Functions
This study has been completed.
Sponsor:
University Hospital, Strasbourg, France
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00295113
First received: September 13, 2005
Last updated: November 28, 2007
Last verified: November 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to observe the ventilatory and cardiac function (included the pulmonary arterial pressure) during an intermittent work exercise test with high density work load.
| Condition | Intervention |
|---|---|
|
Pulmonary Disease, Chronic Obstructive |
Procedure: EFR |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Interest of a 30 Minutes' Intermittent Work Exercise Test in Patients With Chronic Obstructive Pulmonary Disease: Cardiac and Pulmonary Functions |
Resource links provided by NLM:
MedlinePlus related topics:
COPD (Chronic Obstructive Pulmonary Disease)
Exercise and Physical Fitness
U.S. FDA Resources
Further study details as provided by University Hospital, Strasbourg, France:
Primary Outcome Measures:
- The pulmonary arterial pressure does not increase dramatically during the 30 minutes exercise test, but decreases significantly after the first 5 minutes of exercise.
Secondary Outcome Measures:
- The cardiac output is stable after the first 5 minutes of exercise, despite the high intensity work loads every 5 minutes.
| Enrollment: | 10 |
| Study Start Date: | November 2001 |
| Estimated Study Completion Date: | June 2003 |
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- COPD patients (male and female) with moderate obstruction (FEV1/CV<60%)
Exclusion Criteria:
- acute respiratory disease
- any type of cardiac disease
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00295113
Locations
| France | |
| Hôpitaux Universitaires de Strasbourg - Service des Explorations Fonctionnelles | |
| Strasbourg, France, 67091 | |
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
| Principal Investigator: | Ruddy RICHARD, MD | Hôpitaux Universitaires de Strasbourg - Service des Explorations Fonctionnelles Respiratoires et de l'Exercice |
| Principal Investigator: | Evelyne LONSDORFER-WOLF, MD | Hôpitaux Universitaires de Strasbourg - Service des Explorations Fonctionnelles Respiratoires et de l'Exercice |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00295113 History of Changes |
| Other Study ID Numbers: | 2398 |
| Study First Received: | September 13, 2005 |
| Last Updated: | November 28, 2007 |
| Health Authority: | France: Ministry of Health |
Keywords provided by University Hospital, Strasbourg, France:
|
Pulmonary arterial pressure COPD Cardiac output pulmonary and cardiac functions pulmonary arterial pressure measurements |
Additional relevant MeSH terms:
|
Chronic Disease Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive |
Lung Diseases, Obstructive Disease Attributes Pathologic Processes Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 23, 2013